Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
News headline image
No More Free COVID-19 At-Home Tests, Federal Government Says ↗
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Expert Ratings for Exact Sciences ↗
Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings: 
Via Benzinga
News headline image
Expert Ratings for Exact Sciences ↗
Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
What 9 Analyst Ratings Have To Say About Exact Sciences ↗
Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
5 Top Stocks Cathie Wood Bought This Week ↗
Cathie Wood continues to increase positions in some of her top stocks despite recession fears. She bought names like EXAS and PACB this week. 
Via InvestorPlace
News headline image
Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead ↗
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund. 
Via Benzinga
News headline image
Exact Sciences: Q2 Earnings Insights ↗
Exact Sciences (NASDAQ:EXAS) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Exact Sciences beat estimated... 
Via Benzinga
News headline image
Small Cap Biotech Stocks Are Trending Well ↗
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx. 
Via Talk Markets
News headline image
Non-COVID Sales Boost Exact Sciences' Q1 Revenue; Revises FY22 Guidance ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 26, 2022 ↗
Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.09 per share on revenue of $46.41 million. 
Via Benzinga
News headline image
Analyst Ratings for Exact Sciences ↗
Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings: 
Via Benzinga
News headline image
Earnings Scheduled For February 22, 2022 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
News headline image
6 Cathie Wood Stocks to Buy on the Dip ↗
As major holdings in her portfolios, these Cathie Wood stocks to buy on the dips are likely to significantly pop when the market recovers. 
Via InvestorPlace
News headline image
5 Cathie Wood Stocks to Buy in June ↗
These are the five best Cathie Wood stocks to buy in June. EXAS, IONS, KTOS, TRMB, and PATH can make excellent investments. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022 ↗
 
Via Benzinga
News headline image
Why Ark Innovation ETF Hit 52-Week Lows Today ↗
ARK Innovation ETF (ARCA:ARKK) is making new 52-week lows on Monday, led by sharp declines in the top holdings of Ark's flagship fund. 
Via Benzinga
News headline image
9 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Exact Sciences's Return On Capital Employed Insights ↗
According to data from Benzinga Pro, during Q1, Exact Sciences's (NASDAQ:EXAS) reported sales totaled $486.57 million. Despite a 17.98% increase in earnings, the company posted a loss of $180.94... 
Via Benzinga
News headline image
SVB Leerink Maintains Outperform Rating for Exact Sciences: Here's What You Need To Know ↗
SVB Leerink has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $130.00 to $95.00. Shares of Exact Sciences are trading up 7.86% over the last... 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Exact Sciences Stock In The Last 10 Years ↗
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 10 years by 7.98% on an annualized basis producing an average annual return of 19.54%. Currently, Exact Sciences has a market... 
Via Benzinga
News headline image
Preview: Exact Sciences's Earnings ↗
Exact Sciences (NASDAQ:EXAS) is set to give its latest quarterly earnings report on Tuesday, 2022-04-26. Here's what investors need to know before the announcement. Analysts estimate that Exact... 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Exact Sciences 20 Years Ago Would Be Worth Today ↗
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 20 years by 2.83% on an annualized basis producing an average annual return of 10.04%. Currently, Exact Sciences has a market... 
Via Benzinga
News headline image
How do Biotechnology Funds and ETFs Perform Over Five Years? ↗
Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV. 
Via Talk Markets
News headline image
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much ↗
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 5 years by 12.08% on an annualized basis. Buying $100 In EXAS: 5 years ago, an investor could have... 
Via Benzinga
News headline image
Tesla, Coinbase, Exact Sciences And More: How Cathie Wood's Top 10 Bets Are Faring In 2022 So Far ↗
Popular stockpicker Cathie Wood-led Ark Investment Management’s top ten key bets — spread across clean energy, innovation, tech, healthcare, and space... 
Via Benzinga
News headline image
Where Exact Sciences Stands With Analysts ↗
Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked... 
Via Benzinga
News headline image
Exact Sciences Clocks 16% Jump In Q4 Non-COVID-19 Revenues ↗
Exact Sciences Corp's (NASDAQ: EXAS) Q4 revenues increased 2% Y/Y to $473.8 million and beat the average Wall Street estimate of $449 million. Excluding COVID-... 
Via Benzinga
News headline image
4 Big Ark Innovation Components Report Earnings This Week: Could It Spell More Danger For Cathie Wood? ↗
The Ark Funds ETFs have been hit hard in 2022 with growth stocks among the laggards as investors turned to value stocks. Many stockholders have begun to question ... 
Via Benzinga
News headline image
Exact Sciences: Q4 Earnings Insights ↗
Exact Sciences (NASDAQ:EXAS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.